Read about how Dallas-based Gradalis, Inc’s FANG Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
http://bionews-tx.com/news/2013/05/16/gradalis-incs-fang-personalized-tumor-vaccine-stimulates-immune-response-and-more-than-doubles-time-to-recurrence-in-patients-with-advanced-stage-ovarian-cancer/
No comments:
Post a Comment